Valuation: LataMed AI Corp.

Market Cap 7.23M 6.47M 5.97M 5.4M 10.11M 688M 10.27M 71.25M 28.42M 360M 27.12M 26.54M 1.14B P/E 2024
-3.63x
P/E 2025 -102x
Enterprise Value 7.62M 6.83M 6.3M 5.7M 10.66M 726M 10.83M 75.14M 29.98M 380M 28.6M 28M 1.2B EV / Sales 2024
-
EV / Sales 2025 -
Free-Float
96.45%
Yield 2024 *
-
Yield 2025 -
09-09 LataMed AI VE Enters Healthcare Technology Cooperation Agreement with Venezuelan Science and Health Ministries for La Guaira Deployment CI
09-09 Latamed Ai Corp. Enters Healthcare Technology Cooperation Agreement with Venezuela?s Ministry of Popular Power for Science and Technology and Ministry of Popular Power for Health for La Guaira Deployment CI
08-19 Latamed Ai Corp. Nears Completion of Mobile Healthcare Application CI
08-12 LataMed AI VE Enters Strategic Collaboration With Caracas FC to Explore AI-Powered Athletic Performance and Operational Analytics CI
08-12 LataMed AI Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 CI
08-03 LataMed AI Corp. And DROGUERIAS LALA C.A. Enter Agreement To Develop AI And Automation Tools For Pharmaceutical And Laboratory Workflows CI
07-31 LataMed AI Corp. And Venezuelan Institute For Scientific Research Enter Agreement To Develop Digital Platform Supporting Access To IVIC Laboratory Services CI
07-28 LataMed AI Corp. Announces Through its Venezuelan Operating Subsidiary Enters Agreements with Colegio Claret and Colegio Roraima to Develop School-Based Digital Healthcare Initiatives CI
07-23 LataMed AI Corp. through its subsidiary LATAMEDAI VE, and FARMASER Enter Memorandum of Understanding to Develop Automation Platform for Pharmacy Operations CI
07-20 LataMed AI Corp Advances Industrial Telemedicine Initiative For Remote And Offshore Operations In Venezuela CI
07-06 LataMed AI Corp. Begins Planned Expansion into Colombia Through Initial Due Diligence and Strategic Planning CI
07-01 Latamed Ai Ve Executes Strategic Commercial Alliance with Cantv to Expand Digital Healthcare Services Across Venezuela CI
06-30 Latamed Ai Corp. and Vértice Seguros C.A. Execute Strategic Commercial Alliance to Expand Digital Healthcare and Insurance Ecosystem CI
1 day-7.50%
1 week-20.55%
Current month-38.33%
1 month-46.14%
3 months-93.27%
6 months-89.84%
Current year-71.54%
1 week 0.03
Extreme 0.03328
0.05
1 month 0.03
Extreme 0.0301
0.07
Current year 0.03
Extreme 0.0301
1.38
1 year 0.03
Extreme 0.0301
1.38
3 years 0.03
Extreme 0.0301
135
5 years 0.03
Extreme 0.0301
135
10 years 0.03
Extreme 0.0301
135
Manager TitleAgeSince
Chief Executive Officer 31 17/02/2026
Director of Finance/CFO 38 31/03/2026
Director TitleAgeSince
Director/Board Member 31 17/02/2026
Change 5-day change 1-year change 3-year change Capi.($)
-7.50%-20.55%-81.29%-99.78% 7.23M
+0.89%+1.85%+23.06%+78.28% 34.03B
+1.89%-2.47%+6.80%+35.56% 24.28B
-1.02%+2.75%+6.49%+23.97% 8.21B
-2.11%-1.15%+79.20%+98.57% 7.59B
+0.35%+3.15%+40.77%+50.67% 6.59B
-1.62%-2.01%+25.78%+115.36% 5.21B
+3.40%+1.59%+71.39%-0.47% 3.67B
-7.50%-17.85%+29.08%+107.04% 2.77B
-1.97%-1.32%-7.23%+61.05% 2.8B
Average -1.56%-2.49%+19.40%+47.03% 9.51B
Weighted average by Cap. +0.32%-0.59%+24.47%+61.71%

Financials

2024 2025
Net sales - -
Net income -3.26M -2.92M -2.69M -2.44M -4.56M -311M -4.63M -32.15M -12.83M -163M -12.24M -11.98M -515M -207K -186K -171K -155K -290K -19.76M -295K -2.05M -816K -10.34M -779K -762K -32.75M
Net Debt 339K 304K 280K 254K 475K 32.32M 482K 3.35M 1.33M 16.91M 1.27M 1.25M 53.57M 395K 354K 326K 295K 552K 37.61M 561K 3.89M 1.55M 19.68M 1.48M 1.45M 62.34M
Projected Income Statement - Annual - LataMed AI Corp.
Logo LataMed AI Corp.
LataMed AI Corp., formerly Catalyst Crew Technologies Corp. is a Venezuela-based company primarily active in the Healthcare Technology sector. The Company is digital health and artificial intelligence technology enterprise, focusing on building telehealth infrastructure, healthcare coordination tools, analytics capabilities, and AI-enabled healthcare solutions for emerging markets. Such technologies are designed d to support healthcare access, patient engagement, provider coordination, emergency medical response, pharmacy integration, insurance accessibility, payment solutions, and data-driven healthcare operations, with an initial regional focus on Latin American markets. The Company owns intellectual property assets relating to its artificial intelligence-enabled healthcare analytics platform, including issued patents and proprietary software, while the modules are in development.
Employees
3
Date Price Change Volume
29/10/26 $0.0370 -7.50% 5,000
28/10/26 $0.0400 0.00% 22,500
27/10/26 $0.0400 +20.19% 187,732
26/10/26 $0.0333 -28.54% 24,130
22/10/26 $0.0466 +3.26% 11,975
  1. Stock Market
  2. Stocks
  3. LMED Stock